get the top three things to know in women's health + wellness, every weekday:

Pathologists Plea: Save the Placenta!

What: A group of pathologists have issued a plea to save placentas after delivery, in an effort to better understand any adverse outcomes in pregnancy – especially those beyond stillbirth, when placentas are most commonly studied. They want to understand what health effects they may reveal for the mother *going forward*. In other words, it’s not just about the pregnancy, but the health of the patient.

Why it matters: “’Placentas should not be considered a waste tissue,’ says senior author Mana Parast, MD, PhD, professor of pathology at University of California San Diego School of Medicine. ‘They can teach us a lot about not just what went wrong in a pregnancy, but also inform about subsequent pregnancies for the health of the pregnant person and baby.’”

Source: Cell Press

More News Snippets
Alcohol’s Lies (and Breast Cancer)

A deep dive on drinking and examining why people reacted far more swiftly to the news that smoking causes cancer than they have for alcohol—especially breast cancer.

OBGYN Pain Goes Beyond IUDs

Sharing the stories of women who have had fibroids removed without pain medication or endometriosis symptoms ignored for years.

Another Mother Dead Thanks to Abortion Bans

Josseli Barnica was excited to be pregnant with her second child but suffered a miscarriage at 17 weeks. Instead of helping the miscarriage progress, doctors let her suffer for 40 hours because her fetus still had a heartbeat.

Could Ozempic Prevent Fibroids?

Women with type 2 diabetes who got a GLP-1 medication were less likely to develop new fibroids than women who just took metformin, a diabetes medication.

The Birth Rate Fallacy

Experts explaining that the global drop in fertility rates is partly a product of women having children later in life.

To Prevent the Cancer from Returning

An essay from Rachel Manteuffel on her breast cancer diagnosis and treatment that manages to be funny while also tackling the wrenching choice to have chemotherapy or not after a mastectomy.